About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Expert Review of Precision Medicine and Drug Development
›
top-articles
Expert Review of Precision Medicine and Drug Development
0.8
(top 50%)
impact factor
218
(top 50%)
papers
1.8K
(top 50%)
citations
17
(top 50%)
h
-index
1.1
(top 50%)
impact factor
276
all documents
1.9K
doc citations
36
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Radiomics: a new application from established techniques
Expert Review of Precision Medicine and Drug Development
2016
262
2
The role of artificial intelligence in precision medicine
Expert Review of Precision Medicine and Drug Development
2017
185
3
Deep learning and radiomics in precision medicine
Expert Review of Precision Medicine and Drug Development
2019
151
4
The economic case for precision medicine
Expert Review of Precision Medicine and Drug Development
2018
66
5
The role of epigenomics in personalized medicine
Expert Review of Precision Medicine and Drug Development
2017
61
6
Use of big data in drug development for precision medicine: an update
Expert Review of Precision Medicine and Drug Development
2019
51
7
Drug repositioning: current approaches and their implications in the precision medicine era
Expert Review of Precision Medicine and Drug Development
2018
48
8
Current approaches and future perspectives on strategies for the development of personalized tissue engineering therapies
Expert Review of Precision Medicine and Drug Development
2016
43
9
The path from big data to precision medicine
Expert Review of Precision Medicine and Drug Development
2016
37
10
Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation
Expert Review of Precision Medicine and Drug Development
2016
34
11
Use of big data in drug development for precision medicine
Expert Review of Precision Medicine and Drug Development
2016
28
12
Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?
Expert Review of Precision Medicine and Drug Development
2020
26
13
Implementation of next generation sequencing in clinical molecular diagnostic laboratories: advantages, challenges and potential
Expert Review of Precision Medicine and Drug Development
2016
25
14
TRAIL pathway targeting therapeutics
Expert Review of Precision Medicine and Drug Development
2018
24
15
Privacy and ethical challenges in next-generation sequencing
Expert Review of Precision Medicine and Drug Development
2019
22
16
Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics
Expert Review of Precision Medicine and Drug Development
2019
21
17
Tissue-based biomarkers in prostate cancer
Expert Review of Precision Medicine and Drug Development
2017
20
18
Precision Dosing in Children
Expert Review of Precision Medicine and Drug Development
2016
18
19
Big data, artificial intelligence, and cardiovascular precision medicine
Expert Review of Precision Medicine and Drug Development
2018
18
20
Applications of digital PCR in precision medicine
Expert Review of Precision Medicine and Drug Development
2017
17
21
Coronary artery disease genetic risk awareness motivates heart health behaviors in the Coriell Personalized Medicine Collaborative
Expert Review of Precision Medicine and Drug Development
2016
16
22
The value of genetic risk scores in precision medicine for diabetes
Expert Review of Precision Medicine and Drug Development
2018
15
23
Pharmacogenomics of drugs used to treat brain disorders
Expert Review of Precision Medicine and Drug Development
2020
15
24
The role of metabolomics in precision medicine
Expert Review of Precision Medicine and Drug Development
2016
13
25
‘You-on-a-chip’ for precision medicine
Expert Review of Precision Medicine and Drug Development
2018
13
26
Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment
Expert Review of Precision Medicine and Drug Development
2018
13
27
Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions
Expert Review of Precision Medicine and Drug Development
2020
13
28
Disease modifying anti-rheumatic drugs in juvenile idiopathic arthritis: striving for individualized therapy
Expert Review of Precision Medicine and Drug Development
2016
12
29
Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision making
Expert Review of Precision Medicine and Drug Development
2017
12
30
Population-level pharmacogenomics for precision drug development in dementia
Expert Review of Precision Medicine and Drug Development
2018
12
31
Givosiran, a novel treatment for acute hepatic porphyrias
Expert Review of Precision Medicine and Drug Development
2021
12
32
Math, magnets, and medicine: enabling personalized oncology
Expert Review of Precision Medicine and Drug Development
2021
12
33
Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectives
Expert Review of Precision Medicine and Drug Development
2021
12
34
Personalized medicine in rheumatoid arthritis: methotrexate polyglutamylation revisited
Expert Review of Precision Medicine and Drug Development
2018
11
35
Slotting metabolomics into routine precision medicine
Expert Review of Precision Medicine and Drug Development
2021
11
36
The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review
Expert Review of Precision Medicine and Drug Development
2021
11
37
Challenges for omics technologies in the implementation of personalized medicine
Expert Review of Precision Medicine and Drug Development
2018
10
38
Proteome-based pathology: the next frontier in precision medicine
Expert Review of Precision Medicine and Drug Development
2021
10
39
Technological advances in precision medicine and drug development
Expert Review of Precision Medicine and Drug Development
2016
9
40
Towards precision medicine in Alzheimer’s disease: deciphering genetic data to establish informative biomarkers
Expert Review of Precision Medicine and Drug Development
2017
9
41
Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes
Expert Review of Precision Medicine and Drug Development
2017
9
42
Personalized peptide vaccines for cancer therapy: current progress and state of the art
Expert Review of Precision Medicine and Drug Development
2017
9
43
Biosensors and personalized drug therapy: what does the future hold?
Expert Review of Precision Medicine and Drug Development
2017
9
44
Human regulatory T cells (Treg) and their response to cancer
Expert Review of Precision Medicine and Drug Development
2019
9
45
Personalizing cognitive-behavioral treatment for pediatric obsessive-compulsive disorder
Expert Review of Precision Medicine and Drug Development
2016
8
46
Personalized management of asthma exacerbations: lessons from genetic studies
Expert Review of Precision Medicine and Drug Development
2016
8
47
Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology
Expert Review of Precision Medicine and Drug Development
2016
8
48
Pharmacogenetic studies of drug response in schizophrenia
Expert Review of Precision Medicine and Drug Development
2016
8
49
The role of the MET/AXL pathway as a new target for multikinase inhibitors in renal cell carcinoma
Expert Review of Precision Medicine and Drug Development
2017
8
50
Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine Trial
Expert Review of Precision Medicine and Drug Development
2019
8
site/software ©
exaly
; All materials licenced under
CC by-SA
.